Colorectal Service/Dept. of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Oncology (Williston Park). 2013 Nov;27(11):1074-8.
Although metastatic colorectal cancer is typically incurable, in a good percentage of patients (20% to 50%) who have oligometastatic disease confined to a single organ-usually the liver-complete metastasectomy can result in cure. However, once the decision to pursue surgery is made, there remain a number of issues that must be addressed in order to ensure the best possible outcome. These include whether to perform synchronous or staged resections of the liver metastasis and the primary colon cancer; whether surgery should be performed before, after, or in the absence of chemotherapy; if chemotherapy is used, which agents will be best; and in patients with locally advanced rectal cancer, whether pelvic radiation should be incorporated into the treatment plan. Unfortunately, there are limited data that can provide guidance in deciding these questions in a particular patient. Here we present the insights we have arrived at through our own considerable experience with this patient population, and we reflect on the relevant studies that are available.
虽然转移性结直肠癌通常无法治愈,但在少数(20%至 50%)寡转移疾病局限于单一器官(通常是肝脏)的患者中,完全转移切除术可实现治愈。然而,一旦决定进行手术,仍有许多问题需要解决,以确保获得最佳的结果。这些问题包括是否进行肝转移和原发结肠癌的同步或分期切除;手术应该在化疗之前、之后或不进行化疗时进行;如果使用化疗,哪些药物将是最佳选择;以及在局部进展期直肠癌患者中,是否应将盆腔放疗纳入治疗计划。不幸的是,在决定特定患者的这些问题时,数据有限,无法提供指导。在这里,我们介绍了我们通过对这一患者群体的丰富经验所获得的见解,并对现有的相关研究进行了反思。